Abstract 1183: A first-in-class and SHP1 allosteric inhibitor, SB8091, shows a good efficacy and safety profile in preclinical models

Authors: Jun Gyu Kim, Ki Moon Ryu, Jongho Cho, Dajeong Kim, Dae Hyeon Seong, Kyu Hwan Kim, Ik-Soo Jang, Jeong Yoon Shin, Seo Yoon Jeong, Mi Yeon Jang, Hong Sik Han, Joon Yonug Hwang, Dae Young Lee, Chae Lim Ryu, Song yi Lee, Han Eol Kim, Hyung Ki Lee, Han Young Lee, Tae-Dong Han, SeungMin Yang, Hyounmie Doh

Published: 2024-03-22

DOI: 10.1158/1538-7445.am2024-1183

Source: Full article